| ||||||||||||||
|
|
|||||||||||||


*Centre for Anaesthesia, University College London;
Department of Anaesthesia and Critical Care, Institute of Child Health, University College London, London, United Kingdom; and
Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina
Address correspondence and reprint requests to Elliott Bennett-Guerrero, MD, Duke Clinical Research Institute, Duke University (Anesthesiology-Box 3094), Durham, NC 27710. Address e-mail to benne011{at}mc.duke.edu.
Gastrointestinal feeding-related complications (GICs) are common in critically ill patients. Unfortunately, patients at risk for GICs cannot be easily identified. Therefore, we performed a prospective study of 20 critically ill patients to determine the association between a pentagastrin-stimulated gastric acid production test and GICs. Before feeding, the change in the pH of gastric juice was measured in response to a subcutaneous injection of pentagastrin (Gastrotest). We recorded GICs and the feeding volume ratio during each patients intensive care unit (ICU) stay. Nineteen patients data were analyzed and 9 patients (47%) developed
1 GIC, including large gastric residuals, 26%; abdominal distension, 26%; and vomiting, 21%. Patients with GICs had a longer length of ICU stay (mean 21.3, range 545 versus 10.1, range 332; P < 0.05). The 9 patients (47%) who were Gastrotest responders before starting enteral feeding exhibited a significantly larger volume ratio (P = 0.01) and fewer GICs (1 [11%] versus 8 [80%]; P < 0.05). Abdominal distension was seen in only nonresponders. The positive and negative predictive values for this tests ability to predict GICs were 80% and 88.9%, respectively. Responding to a pentagastrin-stimulated gastric luminal acid production test is associated with the administration of larger volumes of enteral feed and fewer GICs.
|